Skip over main navigation
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassadors
      • Tracey Spicer
      • Bloom
    • Our impact
    • Annual reports
    • Position Statements
    • Contact us
  • Information
    • Post-Exertional Malaise
    • ME/CFS Information
    • Long COVID
    • Management
    • For health professionals
    • For carers
    • Member stories
  • Research
    • ME/CFS biobank and registry
    • Long COVID Registry
    • Research Digest
    • Get involved in Research
    • Health and Wellbeing Survey
  • How to get help
    • Patient Support and Information Services
    • Telehealth Nurse Service
    • Online Community
    • GP Education Program
    • Accessing financial support
      • About NDIS
      • About DSP
      • NDIS and DSP Application Resources
      • Debt Helplines
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Gift In Will
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Week
  • Forum
  • News
  • Admin
    • Log in
  • Basket: (0 items)
  • Research Digest 30/3/23

    Research Digest 30/3/23

    Welcome to the Research Digest’s 93rd edition. This month's edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID and finally, a local study sheds light on brain structure changes that are common to Long COVID and ME/CFS. Read more

  • Research Digest 22/12/22

    Research Digest 22/12/22

    Welcome to the 91st edition of the Research Digest.  In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid.   The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilson’s call for the government to better recognise those living with invisible disabilities. Read more

  • Research Digest 30/3/23
  • Research Digest 22/12/22
  • Next
  • Prev
  1. Home
  2. Research Digest

Research Digest

You can also join our community and choose to have the Research Digest delivered straight to your inbox every month on a Friday afternoon by signing up to our mailing list here.

We appreciate the support of everyone who reads the Research Digest – we encourage regular subscribers to support us with a suggested donation of $2. You can donate here.

Research Digest 30/3/23

Research Digest 30/3/23

Welcome to the Research Digest’s 93rd edition. This month's edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID and finally, a local study sheds light on brain structure changes that are common to Long COVID and ME/CFS. Read more

Published: 30th March, 2023

Author: Michelle Tavoletti

Research Digest 23/2/23

Research Digest 23/2/23

Welcome to the Research Digest’s 92nd edition. This month recapitulates research studies that extend our understanding of ME/CFS and Long COVID. The effect of exercise on the content of extracellular vesicles is investigated for ME/CFS and for Long COVID symptoms. This edition also highlights comments made by Professor Brendan Crabb, CEO of the Burnet Institute encouraging the government to ‘change the narrative’ to prevent the infection of COVID-19 and limit the impact of Long COVID. Read more

Published: 23rd February, 2023

Updated: 30th March, 2023

Author: Michelle Tavoletti

Research Digest 22/12/22

Research Digest 22/12/22

Welcome to the 91st edition of the Research Digest.  In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid.   The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilson’s call for the government to better recognise those living with invisible disabilities. Read more

Published: 21st December, 2022

Author: Michelle Tavoletti

Research Digest 01/12/22

Welcome to the 90th edition of the Research Digest. This month's edition features ME/CFS studies investigating microclotting and antibody targeting of gut bacteria. Also presented, is the study of serum samples from post-covid syndrome and -/+ME/CFS patients, to further study endothelial dysfunction and the role of angiogenesis in both study groups. And finally, the recent ABC news article featuring Chris Armstrong and Anne Wilson is highlighted. Read more

Published: 1st December, 2022

Updated: 30th March, 2023

Author: Michelle Tavoletti

Research Digest 27/10/22

Welcome to the 89th edition of the Research Digest. This edition features a study looking more closely at blood cells to investigate mitochondrial abnormalities and immunological changes in ME/CFS. Furthermore, the effect of whole-body cryotherapy and activity monitoring in patients living with ME/CFS is presented. A link to Anne Wilson's (Emerge Australia’s CEO) interview, responding to the lack of funding for ME/CFS and Long COVID services in the federal budget is also highlighted. Read more

Published: 27th October, 2022

Updated: 23rd February, 2023

Author: Michelle Tavoletti

Research Digest 29/09/22

Welcome to the 88th edition of the Research Digest. This edition features a study that aimed to determine the value of a simple, objective office-based test in the evaluation of OI and brain fog and large genetic association study that sought to identify chromosomal regions that may be linked to ME/CFS. Read more

Published: 28th September, 2022

Updated: 21st December, 2022

Author: Jessica Kauhausen

Research Digest 25/08/22

Welcome to the 87th edition of the Research Digest. This month's edition highlights emerging evidence of endothelial dysfunction, to further demonstrate the striking similarities of Long Covid to ME/CFS. The metabolism of tryptophan and the role of its metabolites are also presented and postulated to influence symptoms of ME/CFS, as well as suggested mechanisms that may be responsible for the neuroinflammation observed in both ME/CFS and Long Covid. Read more

Published: 25th August, 2022

Updated: 21st December, 2022

Author: Michelle Tavoletti

Research Digest 28/07/22

Welcome to the 86th edition of the Research Digest. This edition reviews research articles looking further into infectious mononucleosis and its links with ME/CFS and the impact of ME/CFS, on the quality of life for patients and their partners.  The digest also presents a recent ME/CFS brain imaging study that may prove useful diagnostically in the future and highlights the 2GB radio interview, featuring Emerge Australia’s CEO Anne Wilson, discussing the impact of changes to Telehealth. Read more

Published: 28th July, 2022

Updated: 26th October, 2022

Author: Michelle Tavoletti

Research Digest 30/06/22

Welcome to the 85th edition of Emerge Australia’s Research Digest. As a special edition, this month’s digest recapitulates Emerge Australia’s ME/CFS Awareness Week Research Panel webinar, providing insight into how our local ME/CFS community is contributing to ME/CFS research in Australia; via their contributions to the ME/CFS Biobank and You+ME Registry Australia. Read more

Published: 30th June, 2022

Updated: 28th September, 2022

Author: Michelle Tavoletti

Load more Back to top

Showing 10 of 93

Latest

  • Research Digest 30/3/23

    Research Digest 30/3/23

    Welcome to the Research Digest’s 93rd edition. This month's edition summarises research that investigates factors that influence the prognosis of ME/CFS and demonstrates that high muscle sodium content, maybe a contributing factor to the pathophysiology of ME/CFS. A review is also highlighted that conveys what is presently known about Long COVID and finally, a local study sheds light on brain structure changes that are common to Long COVID and ME/CFS.

  • Run Melbourne 2023

    Run Melbourne 2023

    We're participating in Run Melbourne 2023. Join now to help reach our goal by running, walking or performing your own activity with us!

  • Tom’s buzz for ME/CFS

    Tom’s buzz for ME/CFS

    I'm fundraising to give hope and help to the 250,000 people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) across Australia, including my older brother Zach.

  • GP Education at GPCE in 2023

    GP Education at GPCE in 2023

    We know how difficult it is to find a GP with knowledge of ME/CFS. One of the main aims for our GP education program is to grow the GP workforce confident to take on people with complex presentations.

Most read

  • Contact Us

    Contact Us

    Emerge Australia provides an information line where you can find out about the latest news and information about ME/CFS.

  • What we do

    What we do

    Who we are and what we do

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Post-Exertional Malaise (PEM)

    Post-Exertional Malaise (PEM)

    The central feature of ME/CFS, and a common symptom of Long COVID, is post-exertional malaise (PEM). PEM is when symptoms get worse after physical or mental activity.

  • Volunteer with us

    Volunteer with us

    Join our small, friendly and enthusiastic team as a volunteer

  • How is functional impairment assessed?

  • Annual reports

    Annual reports for Emerge Australia

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, digestive, immune and cardiac systems. ME is classified as a neurological disorder by the World Health Organization.

  • Patient Advisory Group

    Patient Advisory Group

    The Patient Advisory Group provides Emerge Australia with ongoing advice about the needs of the community, as well as invaluable input into projects

Sign up to our newsletter

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
1800 865 321
03 9529 1344
[email protected]

Media enquiries contact Claire Heaney
Mobile: 0421 612 507
Email: [email protected]

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.

Manage Cookie Preferences